| Dr Jessica M Kwock, MD | |
|
100 Foden Rd., West, Suite 203, South Portland, ME 04106-2327 | |
| (207) 523-3900 | |
| (207) 523-8593 |
| Full Name | Dr Jessica M Kwock |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 12 Years |
| Location | 100 Foden Rd., West, South Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780941997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD21791 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermed Pa | 5092605261 | 149 |
News Archive
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced that the first healthy human volunteers have been initially dosed in its Phase I clinical trial to evaluate ANAVEX 2-73, the company's lead compound for Alzheimer's disease.
The surgeon who more than two decades ago pioneered deep brain stimulation surgery in the United States to treat people with Parkinson's disease and other movement disorders has now developed a new way to perform the surgery - which allows for more accurate placement of the brain electrodes and likely is safer for patients.
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.
We classified ‘long-term' cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that's used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.
› Verified 4 days ago
| Entity Name | Intermed Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467422733 PECOS PAC ID: 5092605261 Enrollment ID: O20040319000548 |
News Archive
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced that the first healthy human volunteers have been initially dosed in its Phase I clinical trial to evaluate ANAVEX 2-73, the company's lead compound for Alzheimer's disease.
The surgeon who more than two decades ago pioneered deep brain stimulation surgery in the United States to treat people with Parkinson's disease and other movement disorders has now developed a new way to perform the surgery - which allows for more accurate placement of the brain electrodes and likely is safer for patients.
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.
We classified ‘long-term' cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that's used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica M Kwock, MD 100 Gannett Dr Ste C, South Portland, ME 04106-5900 Ph: (207) 828-0361 | Dr Jessica M Kwock, MD 100 Foden Rd., West, Suite 203, South Portland, ME 04106-2327 Ph: (207) 523-3900 |
News Archive
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced that the first healthy human volunteers have been initially dosed in its Phase I clinical trial to evaluate ANAVEX 2-73, the company's lead compound for Alzheimer's disease.
The surgeon who more than two decades ago pioneered deep brain stimulation surgery in the United States to treat people with Parkinson's disease and other movement disorders has now developed a new way to perform the surgery - which allows for more accurate placement of the brain electrodes and likely is safer for patients.
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.
We classified ‘long-term' cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that's used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.
› Verified 4 days ago
Patrick M Benson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Rd. West, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Dr. Christina E Killoran, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Rd, West, Suite 100, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Kathy A Bush, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Road West, Suite 100, South Portland, ME 04106 Phone: 207-523-3900 Fax: 207-523-8593 | |
Kenneth Galeckas, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Road, West, Suite 100, South Portland, ME 04106 Phone: 207-523-3900 | |
Dr. Joel A Sabean, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 350 Cottage Rd, South Portland, ME 04106 Phone: 207-767-2146 Fax: 207-799-1858 | |
Thomas Samuel Bander, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 1, South Portland, ME 04106 Phone: 207-661-0100 |